31330 Federal Register / Vol. 72, No.
108 / Wednesday, June 6, 2007 / Notices
FEDERAL MARITIME COMMISSION
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
AGENCY: Federal Maritime Commission.
Final notice of submission for
ACTION:
OMB review.
SUMMARY: In accordance with the
Paperwork Reduction Act of 1995, the
Federal Maritime Commission hereby
gives notice that it has submitted to the
Office of Management and Budget a
request for an extension of the existing
collection requirements under 46 CFR
515—Licensing, Financial
Responsibility Requirements and
General Duties for Ocean Transportation
Intermediaries and Related Forms. The
FMC has requested an extension of an
existing collection as listed below.
DATES: Written comments on this final
notice must be submitted on or before
July 6, 2007.
ADDRESSES: Comments should be
addressed to: Office of Information and
Regulatory Affairs, Office of
Management and Budget, Attention:
Desk Officer for Federal Maritime
Commission, 725–17th Street, NW.,
Washington, DC 20503,
OIRA_Submission@OMB.EOP.GOV or
fax (202) 395–5806, and to Peter J. King,
Director, Office of Administration,
Federal Maritime Commission, 800
North Capitol Street, NW., Washington,
DC 20573, (Telephone: (202) 523–5800),
administration@fmc.gov. Please
reference the information collection’s
title and OMB number in your
comments.
FOR FURTHER INFORMATION CONTACT: To
obtain additional information, copies of
the information collection and
instructions, or copies of any comments
received, contact Jane Gregory,
Management Analyst, Office of
Administration, Federal Maritime
Commission, 800 North Capitol Street,
NW., Washington, DC 20573,
(Telephone: (202) 523–5800),
jgregory@fmc.gov.
SUPPLEMENTARY INFORMATION: A notice
that FMC would be submitting this
request was published in the Federal
Register on March 26, 2007, allowing
for a 60-day comment period. No
comments were received.
The FMC hereby informs potential
jlentini on PROD1PC65 with NOTICES
respondents that an agency may not
conduct or sponsor, and that a person is
not required to respond to, a collection
of information unless it displays a
currently valid OMB control number.
VerDate Aug<31>2005 16:59 Jun 05, 2007 Jkt 211001
Information Collection Open for
Comment
Title: 46 CFR 515—Licensing,
Financial Responsibility Requirements
and General Duties for Ocean
Transportation Intermediaries and
Related Forms.
OMB Approval Number: 3072–0018
(Expires July 31, 2007).
Abstract: Section 19 of the Shipping
Act of 1984 (the ‘‘Act’’), 46 U.S.C.
40901–40904 (2006), as modified by
Public Law 105–258 (The Ocean
Shipping Reform Act of 1998) and
Section 424 of Public Law 105–383 (The
Coast Guard Authorization Act of 1998),
provides that no person in the United
States may act as an ocean
transportation intermediary (OTI) unless
that person holds a license issued by the
Commission. The Commission shall
issue an OTI license to any person that
the Commission determines to be
qualified by experience and character to
act as an OTI. Further, no person may
act as an OTI unless that person
furnishes a bond, proof of insurance or
other surety in a form and amount
determined by the Commission to
ensure financial responsibility. The
Commission has implemented the
provisions of section 19 in regulations
contained in 46 CFR 515, including
financial responsibility forms FMC–48,
FMC–67, FMC–68, and FMC–69,
Optional Rider Forms FMC–48A and
FMC–69A, and its related license
application form, FMC–18.
Current Actions: There are no changes
to this information collection, and it is
being submitted for extension purposes
only.
Type of Review: Extension.
Needs and Uses: The Commission
uses information obtained under this
part and through Form FMC–18 to
determine the qualifications of OTIs and
their compliance with shipping statutes
and regulations and to enable the
Commission to discharge its duties
under the Act by ensuring that OTIs
maintain acceptable evidence of
financial responsibility. If the collection
of information were not conducted,
there would be no basis upon which the
Commission could determine if
applicants are qualified for licensing.
Frequency: This information is
collected when applicants apply for a
license or when existing licensees
change certain information in their
application forms.
Type of Respondents: The
respondents are persons desiring to
obtain a license to act as an OTI. Under
the Act, OTIs may be either an ocean
freight forwarder, a non-vessel-operating
common carrier, or both.
PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 E:\FR\FM\06JNN1.SGM
Number of Annual Respondents: The
Commission estimates a potential
annual respondent universe of 4,765
entities.
Estimated Time per Response: The
time per response for completing
Application Form FMC–18 averages 2
hours. The time to complete a financial
responsibility form averages 20 minutes.
Total Annual Burden: The
Commission estimates the total annual
person-hour burden at 3,596 person-
hours.
Bryant L. VanBrakle,
Secretary.
[FR Doc. E7–10898 Filed 6–5–07; 8:45 am]
BILLING CODE 6730–01–P
FEDERAL MARITIME COMMISSION
Notice of Agreements Filed
The Commission hereby gives notice
of the filing of the following agreements
under the Shipping Act of 1984.
Interested parties may submit comments
on agreements to the Secretary, Federal
Maritime Commission, Washington, DC
20573, within ten days of the date this
notice appears in the Federal Register.
Copies of agreements are available
through the Commission’s Office of
Agreements (202–523–5793 or
tradeanalysis@fmc.gov).
Agreement No.: 011741–011.
Title: U.S. Pacific Coast-Oceania
Agreement.
Parties: A.P. Moller-Maersk A/S;
Hamburg-Süd; and Hapag-Lloyd AG.
Filing Party: Wayne R. Rohde, Esq.;
Sher & Blackwell LLP; 1850 M Street,
NW.; Suite 900; Washington, DC 20036.
Synopsis: The amendment changes
the structure of the services operated
under the agreement, deletes obsolete
language, and provides for a new
minimum duration of the agreement.
Agreement No.: 011794–007.
Title: COSCON/KL/YMUK/Hanjin/
Senator Worldwide Slot Allocation &
Sailing Agreement.
Parties: COSCO Container Lines
Company, Limited; Kawasaki Kisen
Kaisha, Ltd.; Yangming (UK) Ltd.;
Hanjin Shipping Co., Ltd.; and Senator
Lines GmbH.
Filing Party: Robert B. Yoshitomi,
Esq.; Nixon Peabody LLP; 555 West
Fifth Street, 46th Floor; Los Angeles, CA
90013.
Synopsis: The amendment revises the
vessel contributions and fleet capacities
for K-Line and Yangming under the
agreement. The parties request
expedited review.
By Order of the Federal Maritime
Commission.
06JNN1
 Federal Register / Vol. 72, No. 108 / Wednesday, June 6, 2007 / Notices
Dated: June 1, 2007.
Bryant L. VanBrakle,
Secretary.
[FR Doc. E7–10896 Filed 6–5–07; 8:45 am]
BILLING CODE 6730–01–P
FEDERAL MARITIME COMMISSION
Ocean Transportation Intermediary
License Applicants
Notice is hereby given that the
following applicants have filed with the
Federal Maritime Commission an
application for license as a Non-Vessel-
Operating Common Carrier and Ocean
Freight Forwarder-Ocean Transportation
Intermediary pursuant to section 19 of
the Shipping Act of 1984 as amended
(46 U.S.C. Chapter 409 and 46 CFR part
515).
Persons knowing of any reason why
the following applicants should not
receive a license are requested to
contact the Office of Transportation
Intermediaries, Federal Maritime
Commission, Washington, DC 20573.
Non-Vessel-Operating Common Carrier
Ocean Transportation Intermediary
Applicants
CNF International, Inc., 550 E. Carson
Plaza Drive, #112, Carson, CA 90746.
Officers: Paul Wang Lee, President
(Qualifying Individual), Mi Ran Lee,
Secretary.
Evangel Shipping, Inc., 10408 Daines
Drive, Temple City, CA 91780.
Officer: Xiujuan Lai, CEO (Qualifying
Individual).
Champ International Shipping, Inc., 900
Kaighns Avenue, Camden, NJ 08104.
Officer: Roy Barrington Hibbert,
President (Qualifying Individual).
Cargois Inc., 2700 Coyle Avenue, Elk
Grove Village, IL 60007. Officers:
Souck-Sin Lee, Treasurer (Qualifying
Individual), Jong Han Kwon,
President.
Best Shipping Ever, Inc., 734 Grand
Avenue, Unit C, Ridgefield, NJ 07657.
Officer: Young S. Kim, President,
(Qualifying Individual).
Golden Sea USA Inc., 155–06 So.
Conduit Ave., Suite 200, Jamaica, NY
11434. Officers: Zhang, Shen, Vice
President, (Qualifying Individual), Xia
Fang, President.
Dyna Logistics Inc., 2415 S. Sequoia
Drive, Compton, CA 90220. Officers:
Alfie Chi-Yang, Director (Qualifying
Individual), Michelle Yang, Director/
jlentini on PROD1PC65 with NOTICES
Secretary.
Siboney Shipping LLC, 10943 NW 122
Street, Medley, FL 33178. Officer:
Kaye Graham, Owner (Qualifying
Individual).
VerDate Aug<31>2005 16:59 Jun 05, 2007 Jkt 211001
Non-Vessel-Operating Common Carrier
and Ocean Freight Forwarder
Transportation Intermediary
Applicants
AHC Logistics Cargo Consultant, Inc.,
11591 NW 50th Terrace, Doral, FL
33178. Officers: Alberto Jose
Hernandez Crassus, President
(Qualifying Individual), Amy Aracely
Vega, Vice President.
Express International Cargo, Corp., dba
Express Ocean Services, 7220 NW 36
Street, Suite 300, Miami, FL 33166.
Officer: Carlos Adolfo Marzol,
President (Qualifying Individual).
Salviati and Santori Enterprises Inc., 10
East Merrick Road, Suite 200, Valley
Stream, NY 11580, Officers: Richard
Cazan-Cassini, Exec. Vice Pres.
(Qualifying Individual), Francesco
Santori, President.
IPPCO Global Services, Inc., 14589
Industry Circle, La Mirada, CA 90637.
Officers: John W. Gample, III,
Secretary (Qualifying Individual),
Dina T. Gample, President.
Advanced Maritime Transports, Inc. dba
AMT, 16800 Greenspoint Park Drive,
Suite 170N, Houston, TX 77030.
Officers: William E. Netzinger, III,
President (Qualifying Individual),
Alain Vedrines, Director.
Dated: June 1, 2007.
Bryant L. VanBrakle,
Secretary.
[FR Doc. E7–10899 Filed 6–5–07; 8:45 am]
BILLING CODE 6730–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Environmental
Health/Agency for Toxic Substance
and Disease Registry; The Health
Department Subcommittee of the
Board of Scientific Counselors, CDC,
National Center for Environmental
Health (NCEH)/Agency for Toxic
Substances and Disease Registry
(ATSDR): Teleconference Meeting
Notice of Cancellation: This notice
was published in the Federal Register
on May 4, 2007, Volume 72, Number 86,
page 25318. The meeting previously
scheduled to convene on June 4, 2007
has been cancelled.
Contact Person for More Information:
Shirley D. Little, Committee
Management Specialist, NCEH/ATSDR,
1600 Clifton Road, Mail Stop E–28,
Atlanta, GA 30303; telephone 404/498–
0615, fax 404/498–0059; E-mail:
slittle@cdc.gov.
PO 00000 Frm 00063 Fmt 4703 Sfmt 4703
31331
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: May 30, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–10880 Filed 6–5–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2000E–1253]
Determination of Regulatory Review
Period for Purposes of Patent
Extension; RAPLON
AGENCY: Food and Drug Administration,
HHS.
ACTION: Notice.
SUMMARY: The Food and Drug
Administration (FDA) has determined
the regulatory review period for
RAPLON and is publishing this notice
of that determination as required by
law. FDA has made the determination
because of the submission of an
application to the Director of Patents
and Trademarks, Department of
Commerce, for the extension of a patent
which claims that human drug product.
ADDRESSES: Submit written comments
and petitions to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. Submit
electronic comments to http://
www.fda.gov/dockets/ecomments.
FOR FURTHER INFORMATION CONTACT:
Beverly Friedman, Office of Regulatory
Policy (HFD–007), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301–594–2041.
SUPPLEMENTARY INFORMATION: The Drug
Price Competition and Patent Term
Restoration Act of 1984 (Public Law 98–
417) and the Generic Animal Drug and
Patent Term Restoration Act (Public
Law 100–670) generally provide that a
patent may be extended for a period of
up to 5 years so long as the patented
item (human drug product, animal drug
product, medical device, food additive,
or color additive) was subject to
regulatory review by FDA before the
item was marketed. Under these acts, a
product’s regulatory review period
E:\FR\FM\06JNN1.SGM 06JNN1